Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 140.55
-0.481 %
$ 20.5 B
Market Cap
12.72
P/E
BIIB - STOCK-BASED COMPENSATION
Stock-based Compensation BIIB - Biogen Inc.
264 M
LAST VALUE
5.23%
2 YEAR CAGR
10.90%
5 YEAR CAGR
6.84%
10 YEAR CAGR